Jan Grosser

Jan Grosser

Auto-generated profile, based on publicly available information

Jan Grosser

From Cell and Molecular Biology Karolinska Institutet 2024 Stockholm Stockholm Sweden

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2021 in Molecular Cell
Verified
Journal Article
Open access
AWAnika Wiegard
Anika Wiegard
VKVladislav Kuzin
Vladislav Kuzin
Donald CameronDonald Cameron
Donald Cameron
JGJan Grosser
Jan Grosser
MCMichele Ceribelli
Michele Ceribelli
LBLaura Baranello
Laura Baranello
As cells enter mitosis, chromatin compacts to facilitate chromosome segregation yet remains transcribed. Transcription supercoils DNA to levels that can impede further progression of RNA polymerase II (RNAPII) unless it is removed by DNA topoisomerase 1 (TOP1). Using ChIP-seq on mitotic cells, we found that TOP1 is required for RNAPII translocation along genes. The stimulation of TOP1 activity by RNAPII during elongation allowed RNAPII clearance from genes in prometaphase and enabled chromosomal segregation. Disruption of the TOP1-RNAPII interaction impaired RNAPII spiking at promoters and triggered defects in the post-mitotic transcription program. This program includes factors necessary for cell growth, and cells with impaired TOP1-RNAPII interaction are more sensitive to inhibitors of mTOR signaling. We conclude that TOP1 is necessary for assisting transcription during mitosis with consequences for growth and gene expression long after mitosis is completed. In this sense, TOP1 ensures that cellular memory is preserved in subsequent generations.

3 September 2021 in Nature Methods
Verified
Journal Article
Closed access
PDF file
JSJohanna Schott
Johanna Schott
SRSonja Reitter
Sonja Reitter
DLDoris Lindner
Doris Lindner
JGJan Grosser
Jan Grosser
MBMarius Bruer
Marius Bruer
GSGeorg Stoecklin
Georg Stoecklin

9 December 2022 in Science Advances
Verified
Journal Article
Open access
AMALICE MERONI
ALICE MERONI
JGJan Grosser
Jan Grosser
SASumedha Agashe
Sumedha Agashe
NRNatasha Ramakrishnan
Natasha Ramakrishnan
JJJessica Jackson
Jessica Jackson
AVAlessandro Vindigni
Alessandro Vindigni
DNA topoisomerase 1 (TOP1) inhibitors are mainstays of anticancer therapy. These drugs trap TOP1 on DNA, stabilizing the TOP1-cleavage complex (TOP1-cc). The accumulation of TOP1-ccs perturbs DNA replication fork progression, leading to DNA breaks and cell death. By analyzing the genomic occupancy and activity of TOP1, we show that cells adapt to treatment with multiple doses of TOP1 inhibitor by promoting the degradation of TOP1-ccs, allowing cells to better tolerate subsequent doses of TOP1 inhibitor. The E3-RING Cullin 3 ligase in complex with the BTBD1 and BTBD2 adaptor proteins promotes TOP1-cc ubiquitination and subsequent proteasomal degradation. NEDDylation of Cullin 3 activates this pathway, and inhibition of protein NEDDylation or depletion of Cullin 3 sensitizes cancer cells to TOP1 inhibitors. Collectively, our data uncover a previously unidentified NEDD8–Cullin 3 pathway involved in the adaptive response to TOP1 inhibitors, which can be targeted to improve the efficacy of TOP1 drugs in cancer therapy.

13 October 2023 in Science Advances
Verified
Journal Article
Open access
Donald CameronDonald Cameron
Donald Cameron
JGJan Grosser
Jan Grosser
SLSwetlana Ladigan
Swetlana Ladigan
VKVladislav Kuzin
Vladislav Kuzin
EIEvanthia Iliopoulou
Evanthia Iliopoulou
LBLaura Baranello
Laura Baranello
Pancreatic carcinoma lacks effective therapeutic strategies resulting in poor prognosis. Transcriptional dysregulation due to alterations in KRAS and MYC affects initiation, development, and survival of this tumor type. Using patient-derived xenografts of KRAS- and MYC-driven pancreatic carcinoma, we show that coinhibition of topoisomerase 1 (TOP1) and bromodomain-containing protein 4 (BRD4) synergistically induces tumor regression by targeting promoter pause release. Comparing the nascent transcriptome with the recruitment of elongation and termination factors, we found that coinhibition of TOP1 and BRD4 disrupts recruitment of transcription termination factors. Thus, RNA polymerases transcribe downstream of genes for hundreds of kilobases leading to readthrough transcription. This occurs during replication, perturbing replisome progression and inducing DNA damage. The synergistic effect of TOP1 + BRD4 inhibition is specific to cancer cells leaving normal cells unaffected, highlighting the tumor’s vulnerability to transcriptional defects. This preclinical study provides a mechanistic understanding of the benefit of combining TOP1 and BRD4 inhibitors to treat pancreatic carcinomas addicted to oncogenic drivers of transcription and replication.

9 September 2021 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
PWPei-Shang Wu
Pei-Shang Wu
JGJan Grosser
Jan Grosser
Donald CameronDonald Cameron
Donald Cameron
LBLaura Baranello
Laura Baranello
LSLena Ström
Lena Ström
The structural maintenance of chromosome (SMC) complex cohesin mediates sister chromatid cohesion established during replication, and damage-induced cohesion formed in response to DSBs post-replication. The translesion synthesis polymerase Polη is required for damage-induced cohesion through a hitherto unknown mechanism. Since Polη is functionally associated with transcription, and transcription triggers de novo cohesion in Schizosaccharomyces pombe, we hypothesized that transcription facilitates damage-induced cohesion in Saccharomyces cerevisiae. Here, we show dysregulated transcriptional profiles in the Polη null mutant (rad30Δ), where genes involved in chromatin assembly and positive transcription regulation were downregulated. In addition, chromatin association of RNA polymerase II was reduced at promoters and coding regions in rad30Δ compared to WT cells, while occupancy of the H2A.Z variant (Htz1) at promoters was increased in rad30Δ cells. Perturbing histone exchange at promoters inactivated damage-induced cohesion, similarly to deletion of the RAD30 gene. Conversely, altering regulation of transcription elongation suppressed the deficient damage-induced cohesion in rad30Δ cells. Furthermore, transcription inhibition negatively affected formation of damage-induced cohesion. These results indicate that the transcriptional deregulation of the Polη null mutant is connected with its reduced capacity to establish damage-induced cohesion. This also suggests a linkage between regulation of transcription and formation of damage-induced cohesion after replication.

19 January 2023 in Nature Methods
Verified
Journal Article
Closed access
PDF file
JSJohanna Schott
Johanna Schott
SRSonja Reitter
Sonja Reitter
DLDoris Lindner
Doris Lindner
JGJan Grosser
Jan Grosser
MBMarius Bruer
Marius Bruer
GSGeorg Stoecklin
Georg Stoecklin